InvestorsHub Logo

surf1944

01/09/13 6:51 PM

#16 RE: surf1944 #15

4:00PM Sagent Pharma announces the temporary importation of Sodium Bicarbonate Injection, USP (SGNT) 16.47 +0.33 : Co announced that due to the current critical shortage of Sodium Bicarbonate Injection, USP in the United States market, Sagent, in cooperation with the FDA, has initiated the temporary importation into the U.S. of a non-FDA approved 8.4% Sodium Bicarbonate Injection (1 mEQ/mL) from Phebra Pty Ltd., an Australian manufacturer.